Do staff speak up when safety or compliance is in jeopardy?

July 2008
Clinical Trials Administrator;Jul2008, Vol. 6 Issue 7, p77
The article provides insights on how to encourage clinical trial staff to speak up when necessary, in order to protect patient safety. Marsh senior vice president Grena Porto implies that some employees are not empowered to do so. She adds that a stop-the-line culture, in which the lowest-ranking employee can intervene when patient safety or compliance is threatened, requires such attitude to be modeled across the board. Christy Dempsey of PatientFlow Technology cites the need to assure staff that they will be supported by the institution.


Related Articles

  • Do staff speak up when patient safety is at issue?  // Medical Ethics Advisor;May2008, Vol. 24 Issue 5, p56 

    The article explores the stand of health care community staff when faced with patient safety issue. The health care community has long supported staff speaking up to protect patient safety but said some staff members are intimated by superiors and opted not to speak. Several nurses gave their...

  • Efficacy as an Important Facet of "Safety" in Clinical Trials: How Can We Do Our Best for Our Patients? Talbot, George H. // Clinical Infectious Diseases;12/1/2008 Supplement 3, Vol. 47, pS180 

    Ensuring optimal efficacy is an important facet of patient safety during the conduct of a clinical trial, if, by "safety," we mean the anticipation, prevention, and assessment of any event that can have an unfavorable impact on the enrolled patients. This article addresses what could be termed...

  • SCRS forms to represent clinical research community.  // Medical Device Daily;10/18/2012, Vol. 16 Issue 202, p6 

    The article presents information on the Society for Clinical Research Sites. The trade organization was unveiled during the 7th Annual Site Solutions Summit on October 13, 2012. The organization is aimed at representing the voice of clinical research sites within the clinical research...

  • TOWARDS CLARIFICATION OF THE ROLE OF RESEARCH NURSES IN NEW ZEALAND: A LITERATURE REVIEW. Bell, Jeanette // Nursing Praxis in New Zealand;Mar2009, Vol. 25 Issue 1, p4 

    The demand for research nurses has increased markedly in recent years due to a rapidly expanding clinical research environment. Research nursing is becoming increasingly specialised and nurses now hold central positions in the coordination of clinical trials and management of trial related...

  • Is clinical research overrated? Cerrato, Paul L.; Lockwood, Charles J. // Contemporary OB/GYN;Mar2006, Vol. 51 Issue 3, p69 

    Discusses the factor that impedes the adoption of medical care recommended by medical research. Failure of researchers to prove the applicability of the evidenced-based conclusions to everyday practice; Failure of randomized clinical trials to give an accurate picture of a management or the...

  • What constitutes a "clinical trial"?: A survey of oncology professionals. Wright, James R.; Kowaleski, Brenda; Sussman, Jonathan // Trials;2008, Vol. 9, Special section p1 

    Background: What constitutes a "clinical trial" is inconsistently defined in the medical literature. With an initiative by Cancer Care Ontario (CCO) to report institutional clinical trials activity across the province of Ontario, Canada, we sought to investigate the variability in the...

  • Strategies for Recruitment and Retention of Participants in Clinical Trials. Probstfield, Jeffrey L.; Frye, Robert L. // JAMA: Journal of the American Medical Association;10/26/2011, Vol. 306 Issue 16, p1798 

    The authors offer recommendations to help promote recruitment and retention of patients in U.S. clinical trials. Some factors that hinder successful recruitments are lack of awareness to active trials by clinicians, financial constraints and administrative burdens and regulatory requirements....

  • Frequent checks can spot patients at risk.  // Healthcare Risk Management;Oct2007, Vol. 29 Issue 10, p112 

    The article discusses the need for mechanism for a regular rounding on patients waiting for emergency treatment to spot patients at risk, as stated by Grena Porto, senior vice president with Marsh, a consulting firm in Philadelphia, Pennsylvania.

  • Clinical research in India: Great expectations? Thatte, U. M.; Bavdekar, S. B. // Journal of Postgraduate Medicine;Oct-Dec2008, Vol. 54 Issue 4, p318 

    India is considered as a preferred site for conducting global clinical trials. Existence of a large treatment-naïve population, availability of English-speaking, skilled doctors, plenty of clinical material, and cost-savings are obvious advantages for carrying out clinical research in India....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics